Hennion & Walsh Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Hennion & Walsh Asset Management's BSX Position: Q2 2026 in Review
Hennion & Walsh Asset Management reduced its Boston Scientific (BSX) stake by 12% in Q2 2026, selling an estimated $700K and leaving 93,021 shares worth $3.97M. The position accounts for 0.11% of the portfolio, ranked #232.
Hennion & Walsh Asset Management first reported a position in BSX in Q3 2022 and has held it in 16 quarters since. The position peaked at $11.7M in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Hennion & Walsh Asset Management held 93,021 shares of Boston Scientific worth $3.97M as of Q2 2026.
- Hennion & Walsh Asset Management sold 12,885 Boston Scientific shares in Q2 2026, an estimated $700K.
- Boston Scientific made up 0.11% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #232 holding.
- Hennion & Walsh Asset Management first reported a position in Boston Scientific in Q3 2022 and has held it in 16 quarters since.
- Hennion & Walsh Asset Management's Boston Scientific position peaked at $11.7M in Q2 2025.
- 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.